Navigation Links
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
Date:4/17/2008

8 months to examine the long-term effects of the treatment.

Cognitive, behavioral and functional measures were collected at baseline, three months and six months of treatment. The primary endpoints of the Phase II trial were cognitive function (as measured by the ADAS-cog) and global impression of change (as assessed by the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) change rating). The secondary endpoints measured changes in beta-amyloid and anti-amyloid antibody levels in blood and cerebrospinal fluid. Safety and tolerability of GAMMAGARD S/D and GAMMAGARD LIQUID treatment in Alzheimer's patients were also assessed relative to placebo.

Phase II Study Results

In August 2007, Baxter and New York-Presbyterian/Weill Cornell announced preliminary Phase II results based on six-month data, indicating the study provided encouragement to carry out a Phase III trial. The criteria for going forward with a Phase III trial were favorable outcomes in GAMMAGARD S/D and GAMMAGARD LIQUID-treated patients relative to those given placebo. The final results of the study re-affirm the decision of Baxter and the ADCS to pursue a multi-center, Phase III study evaluating the role of GAMMAGARD LIQUID for the treatment of patients with mild-to-moderate Alzheimer's disease. The decision was based on results of two completed, open-label clinical studies and the preliminary six-month interim analysis of the Phase II trial.

The Phase II study follows an earlier Phase I study in eight patients carried out at New York-Presbyterian/Weill Cornell that was published in the journal Neurobiology of Aging in February 2008.

Cognitive Function and Global Impression of Change Findings (Primary Endpoints)

After six months, the group of patients treated with GAMMAGARD S/D and GAMMAGARD LIQUID averaged 1.52 points higher than placebo-treated patients (+0.27 versus -1.25) on the ADCS-CGIC score, a commonly used measure of ou
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... August 28, 2015 The global ... USD 49.12 billion by 2020, growing at a CAGR ... new report by Grand View Research, Inc. Monitoring services ... 49.7% from 2014 to 2020.      (Logo: ... along with rising incidences of chronic diseases such as ...
(Date:8/27/2015)... Biosimilars are not generics and the ... and Drug Administration (FDA) for recognizing that each ... guidance issued today. The FDA,s draft guidance on ... calling for biological products to bear a nonproprietary ... reflects the agency,s thinking that "there is a ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... search for a Chief Executive Officer.  Paul Hamelin, Savient,s ... officer, will continue to lead the day-to-day operations of ... About Savient Pharmaceuticals, Inc. Savient ...
... 2010 LuxteL llc , a quality manufacturer of ... the recent sale of their only remaining manufacturing competitor, ... Ceramic Lighting business. Since April 2001, ... compatible with medical lighting produced by Olympus, Storz, Stryker, Wolf, ...
Cached Medicine Technology:Savient Pharmaceuticals Announces Search for CEO 2LuxteL Brand Is the Longest Standing Recognized Name in the Industry 2
(Date:8/28/2015)... ... 28, 2015 , ... Drugs and alcohol abuse by employees ... new approach on solutions in his new book ":Unraveling The Psychological Mystery of ... together for meaningful group meetings. "This would educate the employees on not ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., ... resulting in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and ... the University of Illinois, and then went on to earn his title of Doctor ...
(Date:8/28/2015)... NY (PRWEB) , ... August 28, 2015 , ... The ... Kybella™. It is the first and only nonsurgical product approved by the Food ... Dr. Vito Quatela and Dr. William Koenig are among the ...
(Date:8/28/2015)... ... August 28, 2015 , ... Mendon, IL, home of the Adams ... good people, all for a good cause. In its second year, the “Music With ... by Best Drug Rehabilitation. The “Mission” of “Music With A Mission” is to raise ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, May ... American adults with attention-deficit hyperactivity disorder (ADHD), or the parents ... before finding one that carries the prescription they need to ... affected vary, but much of the focus has been on ...
... Men and women infected with HIV reduced the risk of ... antiretroviral medicines when their immune systems were relatively healthy, according ... National Institute of Allergy and Infectious Diseases (NIAID), part of ... known as HPTN 052, was slated to end in 2015 ...
... . , Neural stem cells can do a lot, but ... usually generated by neural stem cells of the peripheral nervous system, ... nervous system from the stem cells of the brain. However, researchers ... the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have ...
... multicentre study, headed by researchers from Karolinska Institutet in ... mesh can be more effective than traditional surgery. The ... anatomy and more efficient symptom relief, although there is ... published in the renowned scientific periodical The New ...
... a genetic basis, at least in part. A region in ... a key role in this process, as Dr. Ins Ibaez-Tallon ... Medicine (MDC) Berlin-Buch, Germany, have now shown. They also shed ... Neuron , May,12, 2011, Vol. 70, Issue 3, pp: 522-535; ...
... (HealthDay News) -- Giving adrenalin to people with snakebites ... research finds. There,s a high rate of acute ... But giving low-dose adrenaline to patients who have been ... the risk of severe allergic reactions. The ...
Cached Medicine News:Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 2Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 3Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 2Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 3Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 4Health News:A new program for neural stem cells 2Health News:A new program for neural stem cells 3Health News:Synthetic mesh can improve outcome of prolapse surgery 2Health News:Reining in nicotine use 2Health News:Treat Snakebites With Adrenaline, Study Says 2
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
OES Pro Optical Urethrotome...
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
... Stryker's cystoscope line combines ... intuitive and durable hardware. ... incorporate a robust, ergonomic ... connection found on Stryker ...
Medicine Products: